A jury has awarded $18.5 million to four women in a lawsuit against Boston Scientific Corp. The women alleged that Obtryx, an implanted medical device, left them with chronic pelvic pain, chronic infection and pain during intercourse. The trial was heard by a federal jury in West Virginia and is the second verdict against the company over transvaginal mesh devices.
A federal jury in Florida had returned a $26.7 million verdict one week earlier against Boston Scientific for providing insufficient warnings about the risks of its Pinnacle, a pelvic organ prolapse device. Boston Scientific moved too quickly in bringing this product to market. The company also used inappropriate materials, while at the same time, failing to warn doctors and patients about the risks involved. Each of the women will receive $1 million in punitive damages in the verdict.
The multidistrict litigation (MDL) Bellwether case tried in Miami also involved four women suffering injury after having the pelvic mesh implanted. This was the first federal bellwether trial against Boston Scientific, one of seven manufacturers of pelvic mesh that face about 60,000 lawsuits across the country.
As we have reported, transvaginal mesh devices are surgically implanted to treat Pelvic Organ Prolapse (POP) and/or Stress Urinary Incontinence (SUI). For more information on this subject, contact Leigh O’Dell or Chad Cook, lawyers in our firm’s Mass Torts Section, at 800-898-2034 or by email at Leigh.Odell@beasleyallen.com or Chad.Cook@beasleyallen.com.